Bipartisan 'Faster Clinical Trials Act' Proposed to Accelerate Rare Disease Drug Development
A new bipartisan bill titled the 'Faster Clinical Trials Act,' introduced by Representatives Jake Auchincloss and Morgan Griffith, aims to streamline the development of treatments for rare diseases. The legislation proposes creating a network of reusable clinical trial sites and leveraging technologies like computer simulations and wearable devices to allow patients to participate in studies from their homes or local doctors' offices. The bill seeks to reduce the time and cost associated with participant enrollment by at least 30% through an estimated $295 million in FDA funding over five years. By establishing a 'Center for Clinical Trial Innovation,' the act intends to shift the clinical trial model from requiring patient travel to bringing research directly to the patient, potentially benefiting those with rare diseases and conditions like black lung disease.
Topics: Clinical Trials FDA Funding Healthcare Legislation Rare Disease Treatments